52 POSTER Preclinical development of PTC299: an orally bioavailable small molecule drug that selectively inhibits the production of VEGF protein, tumor growth, and microvessel density
| Autor: | Davis, T., Cao, L., Tamilarasu, N., Risher, N., Qi, H., Romfo, C., Bombard, J., Sheedy, J., Weetall, M., Moon, Y. |
|---|---|
| Zdroj: | In EJC Supplements 2006 4(12):20-20 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect